Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
10,001 - 25,000 - Monthly Reach
Unique listeners across all episodes (30 days)
25,001 - 75,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Episode 180 - April 17, 2026
Apr 17, 2026
53m 48s
Episode 179 - April 10, 2026
Apr 10, 2026
59m 55s
Episode 178 - April 3, 2026
Apr 3, 2026
1h 00m 44s
Episode 177 - March 27, 2026
Mar 27, 2026
55m 53s
Episode 176 - March 13, 2026
Mar 13, 2026
1h 00m 32s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/17/26 | Episode 180 - April 17, 2026✨ | public marketsbiotech sector+4 | Chris CarabedianPaul Matteis+2 | XBIKailera+9 | — | biotechIPO+7 | — | 53m 48s | |
| 4/10/26 | Episode 179 - April 10, 2026✨ | biotech sectorpublic markets+4 | Greg SuvannavejhYaron Werber+2 | Financial TimesTrump administration+16 | — | biotechpublic markets+6 | — | 59m 55s | |
| 4/3/26 | Episode 178 - April 3, 2026✨ | biotech deal activityM&A environment+4 | Graig SuvannavejhMike Yee+1 | GLP-1NLRP3 inhibitors+10 | — | biotechM&A+5 | — | 1h 00m 44s | |
| 3/27/26 | Episode 177 - March 27, 2026✨ | biotechmarket volatility+3 | Grace ColónEric Schmidt+1 | AvlayahGilead+14 | — | biotechmarket volatility+3 | — | 55m 53s | |
| 3/13/26 | Episode 176 - March 13, 2026✨ | biotech investor sentimentgeopolitics+5 | Sam FazeliPaul Matteis+1 | FDAGenentech+9 | — | biotechFDA+5 | — | 1h 00m 32s | |
| 3/6/26 | Episode 175 - March 6, 2026✨ | market volatilitycapital markets+5 | Mike YeeEric Schmidt+2 | GLP-1Roivant+3 | Miami | biotechmarket volatility+7 | — | 52m 16s | |
| 2/27/26 | Episode 174 - February 27, 2026✨ | regulatory updatesbiotech acquisitions+3 | Tess CameronAdam Feuerstein | Ebvalloanito-cel+15 | — | FDAbiotech+3 | — | 57m 39s | |
| 2/20/26 | Episode 173 - February 20, 2026✨ | drug developmentbiotech outlook+5 | Eric SchmidtPaul Matteis+3 | FDAModerna+4 | — | biotechFDA+8 | — | 59m 50s | |
| 2/6/26 | Episode 172 - February 6, 2026✨ | biotech IPOsFDA policy+4 | Graig SuvannavejhChris Garabedian+2 | VeradermicsEikon Therapeutics+10 | — | biotechIPO+6 | — | 59m 08s | |
| 1/30/26 | Episode 171 - January 30, 2026✨ | biotech policyFDA updates+4 | John Crowley | BIOFDA+5 | — | biotech raceFDA+7 | — | 59m 25s |
Showing 10 of 10
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
24 placements across 19 markets.
Chart Positions
24 placements across 19 markets.